BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwartz MR, Debski AC, Price RJ. Ultrasound-targeted nucleic acid delivery for solid tumor therapy. J Control Release 2021;339:531-46. [PMID: 34655678 DOI: 10.1016/j.jconrel.2021.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang J, Tang J, Li H, Zhou J, Tang N, Zhu Q, Wang X, Zhu B, Li N, Liu Z. Mechanical destruction using a minimally invasive Ultrasound Needle induces anti-tumor immune responses and synergizes with the anti-PD-L1 blockade. Cancer Lett 2023;554:216009. [PMID: 36400312 DOI: 10.1016/j.canlet.2022.216009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhao Z, Saiding Q, Cai Z, Cai M, Cui W. Ultrasound technology and biomaterials for precise drug therapy. Materials Today 2023. [DOI: 10.1016/j.mattod.2022.12.004] [Reference Citation Analysis]
3 Li G, Zhang Y, Li J. A hybrid nanoassembly for ultrasound-inducible cytosolic siRNA delivery and cancer sono-gene therapy. Ultrason Sonochem 2023;92:106262. [PMID: 36512940 DOI: 10.1016/j.ultsonch.2022.106262] [Reference Citation Analysis]
4 Hsieh HT, Huang HC, Chung CW, Chiang CC, Hsia T, Wu HF, Huang RL, Chiang CS, Wang J, Lu TT, Chen Y. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma. J Control Release 2022;352:920-30. [PMID: 36334859 DOI: 10.1016/j.jconrel.2022.10.047] [Reference Citation Analysis]
5 He S, Singh D, Yusefi H, Helfield B. Stable Cavitation-Mediated Delivery of miR-126 to Endothelial Cells. Pharmaceutics 2022;14. [PMID: 36559150 DOI: 10.3390/pharmaceutics14122656] [Reference Citation Analysis]
6 Wang X, Li C, Wang Y, Chen H, Zhang X, Luo C, Zhou W, Li L, Teng L, Yu H, Wang J. Smart drug delivery systems for precise cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.013] [Reference Citation Analysis]
7 Wang Y, Zhao C, Liu Y, Wang C, Jiang H, Hu Y, Wu J. Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis. Mol Pharm 2022. [PMID: 35436123 DOI: 10.1021/acs.molpharmaceut.2c00073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]